POLR3H
Basic information
Region (hg38): 22:41525799-41544606
Links
Phenotypes
GenCC
Source:
- 46 XX gonadal dysgenesis (Supportive), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (8 variants)
- Optic atrophy 9 (2 variants)
- Infantile cerebellar-retinal degeneration (2 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLR3H gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 11 | 83 | 85 | 190 | ||
Total | 11 | 3 | 99 | 86 | 8 |
Highest pathogenic variant AF is 0.00000657
Variants in POLR3H
This is a list of pathogenic ClinVar variants found in the POLR3H region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-41526182-GCTGC-G | Benign (Jan 06, 2020) | |||
22-41526227-G-T | Likely benign (Aug 30, 2018) | |||
22-41526241-CCT-C | Likely benign (Jul 16, 2023) | |||
22-41526242-C-G | Likely benign (Aug 09, 2022) | |||
22-41526241-C-CCTCTCTA | Likely benign (Jan 07, 2021) | |||
22-41526244-C-T | Likely benign (Sep 06, 2023) | |||
22-41526246-C-T | Likely benign (Aug 19, 2022) | |||
22-41526253-C-A | Likely benign (Aug 10, 2022) | |||
22-41526262-G-A | Uncertain significance (Jun 28, 2022) | |||
22-41526270-G-A | not specified | Likely benign (Nov 02, 2023) | ||
22-41526275-G-A | Uncertain significance (Mar 26, 2022) | |||
22-41526276-T-A | Infantile cerebellar-retinal degeneration | Pathogenic (Aug 01, 2021) | ||
22-41526276-T-C | Likely benign (Dec 25, 2023) | |||
22-41526287-A-G | Infantile cerebellar-retinal degeneration | Pathogenic (Sep 16, 2020) | ||
22-41526289-A-G | Uncertain significance (Jul 25, 2022) | |||
22-41526302-G-A | Conflicting classifications of pathogenicity (Aug 09, 2022) | |||
22-41526316-T-TTCCGTGGGCACTTGGATAACATCTCCAACAACCTGCTCATTGGTGCCATCAACATTGAAAACGGCAAGGCCAAC | Optic atrophy 9 | Likely pathogenic (Jun 23, 2022) | ||
22-41526319-C-T | Infantile cerebellar-retinal degeneration • Optic atrophy 9 | Conflicting classifications of pathogenicity (Jan 10, 2023) | ||
22-41526320-G-A | Uncertain significance (Aug 04, 2023) | |||
22-41526330-G-A | Likely benign (Nov 30, 2022) | |||
22-41526331-GAT-C | Optic atrophy 9 | Likely pathogenic (Jan 09, 2024) | ||
22-41526331-GA-G | Pathogenic (Aug 15, 2022) | |||
22-41526333-T-TA | Pathogenic (Aug 31, 2022) | |||
22-41526336-C-T | Likely benign (Oct 05, 2022) | |||
22-41526338-TCTC-T | Uncertain significance (Oct 27, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POLR3H | protein_coding | protein_coding | ENST00000355209 | 6 | 18803 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00599 | 0.913 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.136 | 123 | 127 | 0.966 | 0.00000742 | 1340 |
Missense in Polyphen | 47 | 41.695 | 1.1272 | 472 | ||
Synonymous | -1.93 | 71 | 53.1 | 1.34 | 0.00000357 | 387 |
Loss of Function | 1.50 | 5 | 10.2 | 0.492 | 4.31e-7 | 120 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000970 | 0.0000967 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I pathway (By similarity). {ECO:0000250, ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Cytosolic DNA-sensing pathway - Homo sapiens (human);RNA polymerase - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Pyrimidine metabolism;Eukaryotic Transcription Initiation;Gene expression (Transcription);Purine metabolism;Pyrimidine metabolism;RNA Polymerase III Transcription Termination;RNA Polymerase III Chain Elongation;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.122
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.26
Haploinsufficiency Scores
- pHI
- 0.149
- hipred
- Y
- hipred_score
- 0.813
- ghis
- 0.624
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.707
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Polr3h
- Phenotype
Zebrafish Information Network
- Gene name
- polr3h
- Affected structure
- hematopoietic multipotent progenitor cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- nucleobase-containing compound metabolic process;transcription by RNA polymerase III;transcription initiation from RNA polymerase III promoter;innate immune response;defense response to virus
- Cellular component
- nucleoplasm;RNA polymerase III complex;centrosome;cytosol;intracellular membrane-bounded organelle
- Molecular function
- RNA polymerase III activity;DNA binding;DNA-directed 5'-3' RNA polymerase activity